Company Filing History:
Years Active: 2007
Title: Innovations by Eduardo S Barriga in Retinal Imaging
Introduction
Eduardo S Barriga is an accomplished inventor based in Albuquerque, NM (US). He has made significant contributions to the field of optical imaging, particularly in the detection of functional signals in retinal images. His innovative work has the potential to enhance the understanding of retinal neuronal activity.
Latest Patents
Eduardo S Barriga holds a patent for a "Method for detecting a functional signal in retinal images." This invention involves a system and method that utilizes an optical imaging device comprising a stimulation light source, an interrogating light source, and a detector. The retina is stimulated by the stimulation light source, followed by illumination with an interrogation light. The reflected intensity from the retina is measured at an interrogating spectral band, which indicates the state of hemoglobin saturation before and after visual stimulation. The optical changes resulting from retinal neuronal activity are captured by the detector. The signal representing the state of hemoglobin saturation is isolated using techniques such as principal components analysis (PCA) and independent component analysis (ICA) algorithms.
Career Highlights
Eduardo S Barriga is associated with Kestrel Corporation, where he applies his expertise in optical imaging and retinal analysis. His work at the company has been instrumental in advancing technologies that can improve medical diagnostics and treatment options for retinal conditions.
Collaborations
Eduardo collaborates with Peter Soliz, contributing to the development of innovative solutions in the field of retinal imaging. Their combined efforts aim to push the boundaries of current technologies and enhance the understanding of retinal health.
Conclusion
Eduardo S Barriga's contributions to retinal imaging through his patented methods demonstrate his commitment to innovation in the field. His work not only advances scientific understanding but also holds promise for future medical applications.